Fundz

One04 Therapeutics secures undisclosed funding from D11Z.Ventures to accelerate the development of CPV-104, a promising treatment for complement-mediated diseases.

PRIVATESep 15, 2026

Round Type

Venture

Freiburg Im BreisgauBiotechnologyTherapeuticsPharmaceuticalBiopharma

Investors

D11Z Ventures

Description

One04 Therapeutics GmbH & Co. KG has announced its launch as a clinical-stage biopharmaceutical company with Phase 1 results for CPV-104. The company has secured funding from D11Z.Ventures to facilitate expansion into kidney diseases and dry AMD. This funding will support key development milestones in 2026 and 2027

Who else raised in Therapeutics and Pharmaceutical around the same time

Companies in the same sectors as One04 Therapeutics GmbH & KG that raised within 45 days of this round, from Fundz verified event records.

  • Quanta Therapeutics raised an undisclosed amount (Series D) on October 24, 2026.
  • Disc raised $422M (Post-IPO Equity) on October 20, 2026.
  • Acta Pharmaceuticals raised $24M (Seed) on October 15, 2026.
  • Os Therapies raised $7.2M on October 15, 2026.
  • Ensho Therapeutics raised $7.3M on October 2, 2026.
  • Breye Therapeutics raised $77M (Series A) on September 29, 2026.

Who to call at One04 Therapeutics GmbH & KG, and when

A new round usually means One04 Therapeutics GmbH & KG is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day One04 Therapeutics GmbH & KG raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at One04 Therapeutics GmbH & KG, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at One04 Therapeutics GmbH & KG. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

One04 Therapeutics GmbH & KG

Location

Freiburg Im Breisgau, Baden Württemberg, Germany

About

One04 Therapeutics GmbH & Co. KG is a clinical-stage biopharmaceutical company focused on developing CPV-104, a first-in-class recombinant human Factor H candidate. The company aims to treat a variety of complement-mediated diseases, with its current focus on kidney diseases and dry age-related macular degeneration. One04 is dedicated to accelerating the development of its therapeutic candidates through strategic independence and optimal operational focus.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment One04 Therapeutics GmbH & KG raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for One04 Therapeutics GmbH & KG's next move

See what Strategic adds

One04 Therapeutics GmbH & KG raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.